Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Net Income (Quarterly): -9.345M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -9.345M |
| June 30, 2023 | -20.96M |
| March 31, 2023 | -22.17M |
| December 31, 2022 | -18.37M |
| September 30, 2022 | -25.10M |
| June 30, 2022 | -22.13M |
| March 31, 2022 | -24.95M |
| December 31, 2021 | -20.09M |
| Date | Value |
|---|---|
| September 30, 2021 | -19.96M |
| June 30, 2021 | -14.89M |
| March 31, 2021 | -15.05M |
| December 31, 2020 | -12.61M |
| September 30, 2020 | -7.303M |
| June 30, 2020 | -6.457M |
| March 31, 2020 | -4.577M |
| December 31, 2019 | -6.077M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-25.10M
Minimum
Sep 2022
-4.577M
Maximum
Mar 2020
-15.63M
Average
-16.71M
Median
Net Income (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | -18.19M |
| Zai Lab Ltd | -95.43M |
| WuXi Biologics (Cayman) Inc | -- |
| Axonics Inc | 6.574M |
| I-MAB | -- |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 16.83M |
| EPS Diluted (Quarterly) | -0.1106 |